Polarean的封面图片
Polarean

Polarean

医疗设备制造业

Durham,NC 3,857 位关注者

Revolutionize pulmonary medicine through direct visualization of lung function.

关于我们

Polarean is a revenue-generating medical imaging technology company revolutionizing pulmonary medicine through direct visualization of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The Company strives to optimize lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarization science and has successfully developed the first and only hyperpolarized Xenon MRI inhaled contrast agent, XENOVIEW?, which is now FDA-approved in the United States. Polarean is dedicated to researching, developing, and commercializing innovative imaging solutions with its noninvasive and radiation-free pulmonary functional MRI platform. This comprehensive drug-device platform encompasses the proprietary Xenon gas blend, gas hyperpolarization system, as well as software and accessories, facilitating fully integrated modern respiratory imaging operations. Founded in 2012, with offices in Durham, NC, and London, United Kingdom, Polarean is committed to increasing global awareness of and broad access to its XENOVIEW MRI technology platform. For the latest news and information about Polarean, please visit www.polarean.com.

网站
https://polarean.com
所属行业
医疗设备制造业
规模
11-50 人
总部
Durham,NC
类型
上市公司
创立
2011
领域
Hyperpolarized Gases、Xenon Polarizer、Pulmonary Imaging、Hyperpolarized Gas MRI、Helium Polarizer、Functional Lung Imaging、Xenon Hyperpolarizer、Helium Hyperpolarizer、ILD、Pulmonary Hypertension、Cystic Fibrosis、IPF、COPD、Interventional Pulmonology和Asthma

地点

Polarean员工

动态

相似主页

查看职位

融资

Polarean 共 2 轮

上一轮

上市后股权

US$12,600,000.00

Crunchbase 上查看更多信息